The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Incyte; MedImmune; Merck Serono; MSD; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Syndax
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with anaplastic thyroid cancer.
 
Lori J. Wirth
Consulting or Advisory Role - Amgen; Blueprint Medicines; Eisai; Loxo; Merck; Novartis
 
Ekkehard Eigendorff
No Relationships to Disclose
 
Jaume Capdevila
No Relationships to Disclose
 
Luis G. Paz-Ares
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Chia-Chi Lin
Consulting or Advisory Role - Boehringer Ingelheim; Boehringer Ingelheim; Novartis
Travel, Accommodations, Expenses - Lilly
 
Matthew H. Taylor
Honoraria - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Novartis
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Eisai
Travel, Accommodations, Expenses - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo
 
Rodryg Ramlau
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
 
Marcus Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Immunocore; Immunovaccine; Merck; Novartis
Research Funding - Merck
Expert Testimony - Merck
 
Jean-Pierre Delord
No Relationships to Disclose
 
Zsolt Horvath
No Relationships to Disclose
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)
Other Relationship - Daiichi Sankyo
 
Paolo A. Ascierto
No Relationships to Disclose
 
Angelica Fasolo
No Relationships to Disclose
 
Dagmar Führer
Honoraria - Eisai; Genzyme; Ipsen; SOBI
Consulting or Advisory Role - Eisai; Genzyme; Ipsen
Research Funding - Ipsen
 
Hongqian Wu
Employment - Novartis
Travel, Accommodations, Expenses - Novartis
 
Geraldine Bostel
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Scott Cameron
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Patents related to drugs being developed by Novartis
Travel, Accommodations, Expenses - Novartis
 
Jason Edward Faris
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Exelixis; Millennium; Roche/Genentech
 
Andrea I. Varga
Consulting or Advisory Role - Clovis Oncology